XTL Biopharmaceuticals Lt...

NASDAQ: XTLB · Real-Time Price · USD
1.33
-0.09 (-6.34%)
At close: Aug 15, 2025, 1:40 PM
1.41
6.02%
After-hours: Aug 15, 2025, 04:00 PM EDT

XTL Biopharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-1.03M -1.78M -1.35M 435K
Depreciation & Amortization
199K n/a 1K 1K
Stock-Based Compensation
264K 3K 14K 37K
Other Working Capital
-58K 45K 25K -31K
Other Non-Cash Items
-1.11M 1.01M -36K -1.47M
Deferred Income Tax
-130K n/a 487K n/a
Change in Working Capital
189K 64K -19K -54K
Operating Cash Flow
-1.62M -707K -901K -1.05M
Capital Expenditures
-54K n/a n/a n/a
Cash Acquisitions
-410K n/a n/a n/a
Purchase of Investments
-14K n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-366K 41K 36K 8K
Investing Cash Flow
-844K 41K 36K 8K
Debt Repayment
-13K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 385K
Financial Cash Flow
1.45M n/a n/a 385K
Net Cash Flow
-1.03M -693K -875K -662K
Free Cash Flow
-1.67M -707K -901K -1.05M